| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,431 |
5,777 |
$2.45M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,524 |
7,028 |
$1.46M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,738 |
7,113 |
$1.11M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,248 |
2,988 |
$809K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,755 |
3,503 |
$413K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
723 |
686 |
$346K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,302 |
1,217 |
$285K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,772 |
5,365 |
$242K |
| G0378 |
Hospital observation service, per hour |
4,429 |
1,892 |
$200K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,092 |
1,946 |
$189K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,729 |
554 |
$131K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,060 |
968 |
$65K |
| 70498 |
|
96 |
90 |
$60K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,507 |
936 |
$48K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
645 |
484 |
$40K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,220 |
368 |
$32K |
| 59025 |
Fetal non-stress test |
381 |
273 |
$30K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
414 |
388 |
$8K |
| 76801 |
|
42 |
39 |
$7K |
| 76830 |
Ultrasound, transvaginal |
135 |
129 |
$6K |
| 70496 |
|
85 |
79 |
$6K |
| 96376 |
|
3,300 |
2,115 |
$5K |
| 97161 |
|
596 |
557 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,652 |
7,654 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,906 |
6,390 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,558 |
3,375 |
$3K |
| 80053 |
Comprehensive metabolic panel |
12,053 |
9,958 |
$2K |
| 93976 |
|
37 |
36 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
72 |
66 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,786 |
5,644 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,183 |
1,119 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,984 |
1,810 |
$995.60 |
| 71045 |
Radiologic examination, chest; single view |
5,378 |
4,853 |
$947.93 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
157 |
90 |
$894.93 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,292 |
4,788 |
$861.01 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,782 |
1,576 |
$699.05 |
| 71046 |
Radiologic examination, chest; 2 views |
765 |
734 |
$662.21 |
| 73630 |
|
293 |
275 |
$634.36 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,759 |
11,629 |
$561.80 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14 |
12 |
$471.16 |
| 93971 |
|
370 |
344 |
$436.78 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,210 |
2,330 |
$401.33 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,466 |
4,416 |
$379.13 |
| 81025 |
|
2,163 |
2,031 |
$364.43 |
| 83690 |
|
5,255 |
4,682 |
$317.52 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
940 |
910 |
$305.25 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
324 |
304 |
$270.35 |
| 81001 |
|
9,600 |
8,563 |
$249.66 |
| 84484 |
|
5,946 |
4,208 |
$236.17 |
| 83880 |
|
1,553 |
1,377 |
$230.32 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
446 |
427 |
$219.04 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
129 |
109 |
$215.40 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
446 |
427 |
$214.26 |
| 73130 |
|
194 |
185 |
$181.94 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,276 |
5,901 |
$176.10 |
| 80306 |
|
1,801 |
1,666 |
$172.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,829 |
4,817 |
$148.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,793 |
1,420 |
$148.35 |
| 85379 |
|
1,913 |
1,746 |
$138.80 |
| 83735 |
|
3,971 |
2,987 |
$121.15 |
| 97165 |
|
14 |
13 |
$113.49 |
| 84703 |
|
3,647 |
3,341 |
$113.01 |
| 87040 |
|
1,796 |
936 |
$109.62 |
| 84702 |
|
658 |
579 |
$107.21 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,527 |
2,847 |
$105.97 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,115 |
1,044 |
$103.75 |
| 82248 |
|
3,422 |
3,123 |
$101.59 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,682 |
2,444 |
$95.34 |
| 85027 |
|
3,966 |
2,881 |
$80.99 |
| 73562 |
|
277 |
253 |
$80.44 |
| 85610 |
|
3,881 |
3,474 |
$69.32 |
| 86850 |
|
358 |
327 |
$58.94 |
| 73110 |
|
98 |
94 |
$58.46 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
113 |
100 |
$46.07 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,107 |
748 |
$45.51 |
| 90715 |
|
142 |
136 |
$43.21 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,783 |
2,742 |
$43.16 |
| 80320 |
|
1,274 |
1,176 |
$37.43 |
| 73030 |
|
141 |
137 |
$35.68 |
| 87077 |
|
1,028 |
854 |
$33.85 |
| 87186 |
|
740 |
635 |
$31.15 |
| 83605 |
|
1,788 |
1,425 |
$31.14 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,334 |
2,661 |
$30.87 |
| 85730 |
|
2,154 |
1,916 |
$29.94 |
| J2060 |
Injection, lorazepam, 2 mg |
1,213 |
964 |
$27.76 |
| 82962 |
|
4,006 |
2,226 |
$27.06 |
| 94760 |
|
2,453 |
1,391 |
$24.06 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
158 |
151 |
$20.59 |
| 82550 |
|
748 |
670 |
$20.40 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
894 |
568 |
$18.38 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
74 |
58 |
$15.48 |
| 85652 |
|
500 |
456 |
$14.03 |
| 87660 |
|
122 |
113 |
$13.28 |
| 87510 |
|
122 |
113 |
$13.28 |
| 87480 |
|
122 |
113 |
$13.28 |
| J2704 |
Injection, propofol, 10 mg |
1,610 |
1,455 |
$11.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,278 |
2,104 |
$8.74 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,177 |
1,046 |
$6.48 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
647 |
591 |
$6.39 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,476 |
1,260 |
$6.17 |
| 87205 |
|
234 |
166 |
$5.48 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,419 |
1,060 |
$5.01 |
| 82947 |
|
12 |
12 |
$2.64 |
| 86901 |
|
673 |
587 |
$1.97 |
| 86900 |
|
604 |
527 |
$1.90 |
| J3490 |
Unclassified drugs |
35 |
29 |
$0.95 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
220 |
177 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
34 |
25 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
964 |
641 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
152 |
83 |
$0.00 |
| 84100 |
|
392 |
270 |
$0.00 |
| 96367 |
|
185 |
168 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
519 |
367 |
$0.00 |
| 97116 |
|
103 |
71 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
351 |
300 |
$0.00 |
| 85014 |
|
219 |
185 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
112 |
104 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
144 |
117 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
77 |
60 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
60 |
59 |
$0.00 |
| 85007 |
|
100 |
92 |
$0.00 |
| 93970 |
|
29 |
27 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
44 |
33 |
$0.00 |
| 73610 |
|
128 |
116 |
$0.00 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$0.00 |
| 81003 |
|
93 |
86 |
$0.00 |
| 73080 |
|
14 |
13 |
$0.00 |
| 80076 |
|
13 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,377 |
2,151 |
$0.00 |
| A9270 |
Non-covered item or service |
1,702 |
300 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,527 |
1,403 |
$0.00 |
| 84132 |
|
353 |
299 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
434 |
390 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
118 |
107 |
$0.00 |
| 80329 |
|
176 |
140 |
$0.00 |
| 73502 |
|
12 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
73 |
54 |
$0.00 |
| 82803 |
|
46 |
41 |
$0.00 |
| 87070 |
|
73 |
55 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
148 |
103 |
$0.00 |
| 86140 |
|
34 |
33 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
29 |
28 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
63 |
54 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
134 |
124 |
$0.00 |
| C1769 |
Guide wire |
44 |
40 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
163 |
67 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
36 |
32 |
$0.00 |
| 0352U |
|
30 |
28 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
22 |
12 |
$0.00 |